BacAlt Biosciences
Overview
BacAlt Biosciences is a biotechnology startup founded in 2023 in Bengaluru, India. It was co-founded by Shruti Kutmutia and Pranav Nair. The company focuses on developing bio-based polymers and specialty ingredients using cutting-edge microbiology, industrial biomanufacturing, and sustainable fermentation techniques. As of 2025, BacAlt Biosciences has raised $2 million in a pre-seed funding round led by Avaana Capital, with participation from Lubrizol InnoVentures, valuing the company at approximately $8 million.
Recent Developments
- September 2025: BacAlt Biosciences raised Rs 18 crore (approximately $2 million) in a pre-seed funding round led by Avaana Capital, with participation from Lubrizol InnoVentures. The funds will be allocated towards scaling R&D processes, building pilot production facilities, expanding the team, and developing go-to-market strategies for geographical expansion.
- The company aims to create high-performance, cost-competitive ingredients that can challenge conventional petrochemical-based products. Its bio-based solutions are deeply rooted in sustainability, focusing on circular feedstocks and non-sterile fermentation.
- 2024: The startup started positioning itself as a pioneer in creating sustainable alternatives to conventional specialty ingredients, focusing on bio-manufacturing processes that convert agro-industrial waste into biopolymers. This approach aims to reduce reliance on microplastic and synthetic materials used in agrochemicals, pharmaceuticals, and other industries.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | January 11, 2023 |
| Headquarters | Bengaluru, India |
| Founders | Shruti Kutmutia, Pranav Nair |
| Revenue | Not Publicly Disclosed |
| Profits | Not Publicly Disclosed |
| Key Investors | Avaana Capital, Lubrizol InnoVentures |
| Industry | Biotechnology, Specialty Ingredients |
| Number of Employees | Not Publicly Disclosed |
Early History
BacAlt Biosciences was founded as a response to the growing demand for sustainable and high-performance specialty ingredients. Recognizing the environmental challenges posed by traditional petrochemical-based ingredients, Shruti Kutmutia and Pranav Nair leveraged their expertise in biotechnology to create BacAlt. The company's early focus was on harnessing waste valorization and innovative fermentation techniques to produce biopolymers. These early initiatives set the foundation for BacAlt's mission to lessen the dependency on unsustainable ingredients and move towards a circular bioeconomy.
Company Profile and Achievements
BacAlt Biosciences operates by producing bio-based alternatives that aim to replace the conventional synthetic and petrochemical ingredients prevalent in various industries. Key achievements of the company include:
- Innovative Bio-manufacturing Techniques: BacAlt uses lean and energy-efficient fermentation technology, which allows for the conversion of agricultural waste into high-performance biopolymers.
- Sustainable Product Development: The company champions a sustainability-first approach, ensuring that its production processes minimize microplastic pollution and support circular economy principles.
- Strategic Partnerships: Collaboration with Lubrizol InnoVentures has allowed BacAlt to enhance its product development initiatives, combining resources to deliver bio-based ingredients with lower environmental impacts.
- Recognition and Investment: With a notable pre-seed investment from Avaana Capital, BacAlt has been able to extend its reach and scale its operations efficiently.
Current Operations and Market Position
BacAlt Biosciences is currently focused on scaling its operations by enhancing its R&D capabilities and setting up pilot production facilities. The company is positioning itself to transition from an import-reliant market to a significant player in the global export market for bio-based specialty ingredients. Leveraging proprietary fermentation platforms and circular feedstock strategies, BacAlt seeks to redefine performance benchmarks in the fields of home care, personal care, agrochemicals, nutraceuticals, and pharmaceuticals.
Conclusion
BacAlt Biosciences is on a promising trajectory to impact the biotechnological landscape by providing sustainable alternatives to conventional specialty ingredients. The startup’s groundbreaking approach in biopolymer production is setting new standards in both product performance and environmental sustainability. As BacAlt continues to expand its technological capacities and market presence, it appears poised to lead the shift towards a circular, bio-based economy, contributing positively towards a more sustainable future.